Klor-con and Oxaliplatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Oxaliplatin (oxaliplatin). Common drug interactions include dehydration among females and colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Oxaliplatin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.

On Jul, 10, 2026

22 people who take Klor-con and Oxaliplatin together, and have interactions are studied.

Klor-con and Oxaliplatin drug interactions.

What are the common drug interactions of Klor-Con and Oxaliplatin, by gender? *:

female:

Dehydration (dryness resulting from the removal of water)
Abdominal mass (localized enlargement or swelling in the human abdomen)
Abdominal pain
Asthenia (weakness)
Blood glucose increased
Chills (felling of cold)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
Diarrhoea
Fatigue (feeling of tiredness)

male:

Colitis (inflammation of colon)
Dehydration (dryness resulting from the removal of water)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
General physical health deterioration (weak health status)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hypovolaemia (a decreased volume of circulating blood in the body)
Infection
Metastatic gastric cancer (cancer types can spread to the stomach from other place)
Pancreatic carcinoma (pancreatic cancer)
Pneumonia

What are the common drug interactions of Klor-Con and Oxaliplatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pulmonary embolism (blockage of the main artery of the lung)
Chills (felling of cold)
Dehydration (dryness resulting from the removal of water)
Depression
Irritable bowel syndrome
Pyrexia (fever)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

50-59:

n/a

60+:

Colitis (inflammation of colon)
Dyspnoea (difficult or laboured respiration)
Infection
Pancreatic carcinoma (pancreatic cancer)
Pruritus (severe itching of the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)
Abdominal pain
Anaemia (lack of blood)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Ascites (accumulation of fluid in the abdominal cavity)

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 7 people, 31.82%
Nausea (feeling of having an urge to vomit): 5 people, 22.73%
Anaemia (lack of blood): 4 people, 18.18%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 18.18%
Indigestion: 4 people, 18.18%
High Blood Pressure: 4 people, 18.18%
Thrombocytopenia (decrease of platelets in blood): 3 people, 13.64%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 13.64%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 13.64%
Constipation: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Oxaliplatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously